Want to join the conversation?
In 2Q16, $ENDP posted revenues of $288MM in its US Branded Pharmaceuticals segment, down 9% from 2Q15. In US Generic Pharmaceuticals, revenues were $565MM, up 67%, primarily attributable to growth from the addition of sales by Par. International Pharmaceuticals revenues were $67MM, down 17% from 2Q15.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.